№ files_lp_4_process_1_33569
File format: docx
Character count: 52291
File size: 139 KB
Koi herpesvirus (KHV) is a significant pathogen in freshwater fish, particularly common carp and its hybrids, affecting aquatic animal health globally.
Year:
2007
Region / city:
Global
Topic:
Aquatic animal health
Document type:
Scientific article
Organization / institution:
World Organisation for Animal Health (OIE)
Author:
Multiple authors (Engelsma et al., Haramoto et al., Waltzek et al., etc.)
Target audience:
Scientists, veterinarians, and aquatic animal health professionals
Effective period:
N/A
Approval date:
N/A
Amendment date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Not specified
Region / city:
Not specified
Theme:
Koi herpesvirus infection, aquaculture
Document type:
Scientific chapter
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, aquaculture professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
A scientific chapter discussing the infection caused by koi herpesvirus (KHV), its agent, host factors, and survival conditions in different environments.
Year:
Not specified
Region / city:
Not specified
Theme:
Koi herpesvirus infection, aquaculture
Document type:
Scientific chapter
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, aquaculture professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
A scientific chapter discussing the infection caused by koi herpesvirus (KHV), its agent, host factors, and survival conditions in different environments.
Document type:
Supplementary tables
Subject:
Epidemiology, clinicopathology and diagnostic testing of herpesvirus infections
Species affected:
Domestic goose (Anser anser domestics); Black swan (Cygnus atratus)
Locations:
Lowood; Townsville; Maryborough; Lockyer Valley; Cairns
Dates covered:
15/01/1989–5/01/2021; 14/02/1991 (swan case)
Number of cases:
6
Number at risk:
159 geese; 4 swans
Number dead:
141 geese; 2 swans
Clinical signs:
Lethargy, recumbency, inappetence, vomiting, diarrhoea, tremors, ataxia, open-mouth breathing, rapid death
Gross pathology findings:
Hepatic petechiae and necrosis, splenomegaly, intestinal plaques and haemorrhages, thymic enlargement, pulmonary congestion
Histopathology findings:
Multifocal necrotising hepatitis, splenitis, enteritis, thymitis, vasculitis, eosinophilic intranuclear inclusion bodies
Diagnostic methods:
PCR, virus isolation, electron microscopy, next generation sequencing, serology, microbiology, ELISA
Viruses identified:
Goose herpesvirus (AnHV-2); distinct herpesvirus (AnHV-3)
GenBank accession numbers:
OR578703; OR578701; OR540300; OR578702; OR578704
Comparative tests performed:
Avian Influenza Type A, Newcastle disease virus, DVE, DHV1, pigeon herpesvirus, rotavirus, Salmonella, botulism, heavy metals
Topic:
Feline infectious respiratory diseases
Document Type:
Veterinary informational summary
Subject:
Upper respiratory infections in cats
Pathogens:
Feline herpesvirus (feline rhinotracheitis virus), feline calicivirus
Animal Species:
Domestic cat
Transmission:
Direct contact with infected cats and aerosol spread from sneezing up to 4 feet
Environmental Survival:
Herpesvirus survives 12–18 hours; calicivirus survives 8–10 days in the environment
Disinfection:
Herpesvirus inactivated by most disinfectants; calicivirus inactivated by bleach or Accel
Risk Factors:
Stress increasing susceptibility to infection
Acute Symptoms:
Sneezing, coughing, nasal discharge, conjunctivitis, fever, inappetence, lethargy
Chronic Manifestations:
Sinusitis, chronic sneezing, persistent nasal or ocular discharge
Additional Signs (Calicivirus):
Tongue ulcers and transient limping in kittens
Typical Disease Duration:
Approximately 7–10 days for herpesvirus and 10–14 days for calicivirus
Treatment Approaches:
Antibiotics for secondary infections, ocular medications, antihistamines, antiviral medications, saline nasal drops, and supportive care
Medications Mentioned:
Doxycycline, Tobramycin, idoxuridine, famciclovir
Preventive Measures:
Vaccination reducing severity of clinical signs but not preventing infection or all strains
Year:
2024
Region / City:
Kassala, Sudan
Subject:
Virology, Blood Transfusion Safety
Document Type:
Research Article
Institution:
Kassala University
Authors:
Doaa M. E. Musa, Abdelrhman A. Mohammed, Yasir B. Ahmed, Duaa H. Ibrahim, Leila M. A. Abdelgader, Ghanem M. Mahjaf, Alhaj S. M. A. Ali, Nadir M. Abuzeid
Target Audience:
Researchers, Medical Professionals, Blood Bank Administrators
Date of Approval:
2022
Date of Changes:
N/A
Note:
Year
Subject:
Viral Hepatitis
Document Type:
Health Department Report
Organization:
Kansas Health Department
Target Audience:
Healthcare providers
Organization:
Department of Veterans Affairs
Facility:
Veterans Affairs Medical Center, San Francisco
Document type:
Infection control policy manual
Author:
C. Diana Nicoll, M.D., PhD
Role of author:
Medical Center Director
Committee:
Infection Control Committee
Revision date:
April 2013
Original publication date:
June 2011
Subject area:
Infection prevention and control in healthcare settings
Target audience:
Medical center employees and clinical staff
Scope:
Patient care, employee health, environmental controls, and outbreak management
Includes sections on:
Standard Precautions, PPE, isolation practices, waste disposal, occupational health, emergency and outbreak management
Year:
2024
Region / City:
Alberta
Topic:
Infection Prevention and Control
Document Type:
Manual
Organization:
Alberta College of Dental Hygienists (ACDH)
Author:
Alberta College of Dental Hygienists
Target Audience:
Oral Healthcare Providers
Period of Validity:
Ongoing, subject to updates
Approval Date:
2024
Date of Changes:
Annually, or as needed
Year:
2016
Region / City:
London, Swindon, Berkshire, Merseyside, Yorkshire, Sunderland
Topic:
Clostridium difficile infection, hospital infection control
Document Type:
Research article
Organization:
Guy’s & St Thomas’ NHS Foundation Trust, Great Western Hospitals NHS Foundation Trust, Heatherwood and Wexham Park Hospitals NHS Foundation Trust, St Helens & Knowsley Hospitals NHS Trust, Calderdale & Huddersfield NHS Foundation Trust, City Hospitals Sunderland NHS Foundation Trust
Author:
Not specified
Target Audience:
Healthcare professionals, researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Context:
A research article detailing the comparison of C. difficile infection control measures across six hospitals in England using whole-genome sequencing to track transmission patterns.
Year:
2000-2013
Region / City:
South Australia
Topic:
Epidemiology, Ross River Virus, Public Health
Document Type:
Research Study
Organization / Institution:
South Australian Department for Health and Wellbeing, University of Adelaide
Author:
Jingwen Liu, Alana Hansen, Scott Cameron, Peng Bi
Target Audience:
Public health professionals, researchers, policymakers
Period of Validity:
2000-2013
Approval Date:
Not specified
Date of Last Update:
Not specified
Year:
2025
Region / city:
Victoria, Australia
Topic:
Health, Urinary Tract Infection, Pharmacist Services
Document type:
Patient handout
Author:
Department of Health, Victoria Government
Target audience:
Women and gender diverse people with female biology aged 18-65, including Medicare and international students
Period of validity:
December 2025
Approval date:
December 2025
Date of updates:
Not specified
Year:
2025
Region / City:
Massachusetts
Topic:
Healthcare Personnel, Respiratory Viral Infections
Document Type:
Guidance
Agency / Institution:
Commonwealth of Massachusetts, Executive Office of Health and Human Services, Department of Public Health
Author:
N/A
Target Audience:
Healthcare Personnel
Effective Date:
September 1, 2025
Date of Approval:
N/A
Date of Amendments:
May 3, 2024
Year:
2023
Region / City:
UK
Theme:
Infection control, respiratory infections
Document Type:
Guidance
Organization / Institution:
UKHSA
Author:
UKHSA
Target Audience:
Care home workers and managers
Period of Validity:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Context:
Guidance for care home workers and managers on infection prevention and control practices to manage outbreaks of acute respiratory infections (ARI) in care home settings.
Year:
2026
Region / City:
Oxford, UK
Document Type:
Referral Form
Institution:
Oxford University Hospitals NHS Foundation Trust
Intended Audience:
General Practitioners, Hospital Consultants
Clinical Focus:
Bone and Joint Infections
Required Attachments:
Imaging, Microbiology Results
Referral Method:
Direct email for hospital referrals, e-referral service for GPs
Patient Eligibility:
UK residents
Organization:
National Healthcare Safety Network (NHSN)
Document type:
Surveillance toolkit
Topic:
Post-discharge surgical site infection surveillance
Healthcare setting:
Ambulatory Surgery Center
Surveillance period:
30-day or 90-day post-operative follow-up
Intended users:
Healthcare facility staff, surgeons, surgeons’ office staff
Source protocol:
NHSN OPC-SSI Protocol
Included materials:
Sample letter, procedure line list by surgeon, post-discharge SSI worksheet
Data reporting system:
NHSN
Scope:
Surgical procedures monitored for superficial, deep, and organ/space SSIs
Year:
2022
Region:
Massachusetts
Jurisdiction:
United States
Topic:
Chlamydia infection; expedited partner therapy; sexually transmitted infections
Document type:
Clinical advisory
Issuing body:
Massachusetts Department of Public Health
Legal basis:
M.G.L. c. 111 § 121B; 105 CMR 700.003(J); 105 CMR 721.000
Target audience:
Healthcare providers and pharmacists
Standard treatment referenced:
Doxycycline; azithromycin
Population referenced:
Adolescents, young adults, men who have sex with men
Date of update:
January 28, 2022
Year:
2023
Region / city:
Global
Theme:
Orthopedic infection management, surgical procedures
Document type:
Academic article
Author:
Metsemakers et al.
Target audience:
Medical professionals, researchers, healthcare providers
Period of validity:
Ongoing
Date of approval:
2023
Date of changes:
Not specified
Year:
2023
Region / City:
United States
Topic:
Infection Control
Document Type:
Policy
Organization / Institution:
[AFH Name]
Author:
[AFH Name] Administration
Target Audience:
Staff
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2024
Region / City:
Wales
Topic:
Healthcare, Pharmacy, Urinary Tract Infection
Document Type:
Patient Group Directions (PGD)
Organisation:
Welsh Medicines Advice Service, NHS Wales
Author:
Dianne Burnett, Louise Allen, Emlyn Pritchard, Adam Mackridge, Richard Coulthard
Target Audience:
Healthcare professionals, community pharmacists
Validity Period:
From 03 June 2024 to 02 June 2027
Approval Date:
22 April 2024
Ratification Date:
09 May 2024
Review Date:
08 February 2027
Expiry Date:
02 June 2027
Version:
1.0
Change History:
Version 1.0 developed on 22 December 2023
Clinical Condition:
Acute, uncomplicated lower urinary tract infection
Treatment:
Nitrofurantoin, Trimethoprim
Applicable Group:
Non-pregnant females or transgender males (16-64 years)
Authorising Organisation:
Local Health Board
Staff Requirements:
Registered pharmacists, authorised by name
Retention Period:
8 years for adults, 25 years for children
Local Inquiries:
[insert local details]
Year:
2024
Region / city:
Victoria, Australia
Topic:
Urinary Tract Infection Treatment
Document Type:
Patient Handout
Organ / Institution:
Department of Health, Victoria
Author:
Department of Health, Victoria
Target Audience:
Women and gender diverse people with female biology aged 18-65
Period of validity:
March 2024
Approval date:
March 2024
Date of amendments:
N/A
Contextual Description:
Patient handout providing details about treatment, eligibility, and self-care for uncomplicated urinary tract infection under a pilot program for community pharmacists.